Terumi Kamisawa

Active 1993–2024

99
Papers
27,315
Citations
79
h-index
98
i10-index

Citations

Citations per year for Terumi Kamisawa1994: 2 citations1997: 1 citations1998: 1 citations1999: 2 citations2000: 1 citations2001: 4 citations2002: 4 citations2003: 7 citations2004: 24 citations2005: 34 citations2006: 82 citations2007: 107 citations2008: 142 citations2009: 155 citations2010: 201 citations2011: 145 citations2012: 198 citations2013: 148 citations2014: 182 citations2015: 181 citations2016: 170 citations2017: 203 citations2018: 161 citations2019: 819 citations2020: 839 citations2021: 618 citations2022: 420 citations2023: 265 citations2024: 559 citations2025: 203 citations2026: 6 citations1995–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 949 citing papers, 19.8% of this breakdownChina: 809 citing papers, 16.9% of this breakdownJapan: 688 citing papers, 14.3% of this breakdownItaly: 337 citing papers, 7% of this breakdownUnited Kingdom: 233 citing papers, 4.9% of this breakdownGermany: 219 citing papers, 4.6% of this breakdownSouth Korea: 146 citing papers, 3% of this breakdownNetherlands: 127 citing papers, 2.6% of this breakdownFrance: 124 citing papers, 2.6% of this breakdownCanada: 118 citing papers, 2.5% of this breakdownSpain: 79 citing papers, 1.6% of this breakdownSweden: 72 citing papers, 1.5% of this breakdown
0%19.8%Other 18.7%

Fields

  • Medicine84%
  • Biochemistry, Genetics and Molecular Biology11.8%
  • Immunology and Microbiology1.6%
  • Engineering0.8%
  • Computer Science0.7%
  • Materials Science0.3%
  • Other0.8%

Topics

  • Pancreatic and Hepatic Oncology Research13.7%
  • IgG4-Related and Inflammatory Diseases10.9%
  • Pancreatitis Pathology and Treatment9.4%
  • Neuroendocrine Tumor Research Advances6.2%
  • Gastrointestinal disorders and treatments4.1%
  • Gallbladder and Bile Duct Disorders3.2%
  • Other52.5%

Coauthors

All papers

Open in search
  1. Pancreatic cancer

    Authors: , , , - The Lancet 2016 cited by 2,212

  2. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas

    Authors: , , , , , , , , , - Pancreatology 2017 cited by 1,748

  3. Consensus statement on the pathology of IgG4-related disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ji Kon Ryu, Takako Saeki, Dushyant V. Sahani, Thomas C. Smyrk, James R. Stone, Masayuki Takahira, George Webster, Motohisa Yamamoto, Giuseppe Zamboni, Hisanori Umehara, John H. Stone - Modern Pathology 2012 cited by 2,577

  4. IgG4-related disease

    Authors: , , , - The Lancet 2014 cited by 1,200

  5. International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tooru Shimosegawa, Hiroki Takahashi, Masayuki Takahira, Atsushi Tanaka, Mark Topazian, Hisanori Umehara, George Webster, Thomas E. Witzig, Motohisa Yamamoto, Wen Zhang, T. Chiba, John H. Stone - Arthritis & Rheumatology 2015 cited by 1,051

  6. International Consensus Diagnostic Criteria for Autoimmune Pancreatitis

    Authors: , , , , , , , , , , , , , - Pancreas 2011 cited by 1,508

  7. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Modern Rheumatology 2012 cited by 1,656

  8. A new clinicopathological entity of IgG4-related autoimmune disease

    Authors: , , , , , , , , - Journal of Gastroenterology 2003 cited by 1,464

  9. Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study

    Authors: , , , , , , , , , , , , , , , , - EBioMedicine 2022 cited by 55

  10. IgG4-related disease in the Japanese population: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Takako Saeki, Hisanori Umehara, Tooru Shimosegawa, Nobumasa Mizuno, Mitsuhiro Kawano, Atsushi Azumi, Hiroki Takahashi, Tsuneyo Mimori, Yoichiro Kamatani, Kazuichi Okazaki, Tsutomu Chiba, Shigeyuki Kawa, Fumihiko Matsuda, Atsushi Kanno, Yoshihiro Okabe, Shinji Katsushima, Tetsuro Inokuma, Yukitaka Yamashita, Yoshitaka Nakai, Takayoshi Nishino, Kozo Kajimura, Mitsushige Shibatoge, Naoki Kanda, Akio Ido, Masaya Ohana, Ichiro Moriyama, Hiroshi Tatsuta, Kazuyoshi Matsumura, Keita Fujikawa, Norimoto Gotoh, Takanobu Tsutsumi, Masakazu Shimizu, Kazuya Setoh, Meiko Takahashi, Yasuharu Tabara, Jun Mimura, Takefumi Nakamura, Toshiyuki Kimura, Chiharu Kawanami - The Lancet Rheumatology 2019 cited by 89

  11. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2012 cited by 582

  12. Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gut 2016 cited by 202

  13. Focal parenchymal atrophy of pancreas: An important sign of underlying high-grade pancreatic intraepithelial neoplasia without invasive carcinoma, i.e., carcinoma in situ

    Authors: , , , , , , , - Pancreatology 2020 cited by 73

  14. International consensus for the treatment of autoimmune pancreatitis

    Authors: , , , , , , , , , , - Pancreatology 2016 cited by 243

  15. Pancreaticobiliary maljunction and congenital biliary dilatation

    Authors: , , , - ˜The œLancet. Gastroenterology & hepatology 2017 cited by 136

  16. Low-dose maintenance steroid treatment could reduce the relapse rate in patients with type 1 autoimmune pancreatitis: a long-term Japanese multicenter analysis of 510 patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2017 cited by 107

  17. Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Takahira, Hisanori Umehara, George Webster, Motohisa Yamamoto, Eunhee S. Yi, Tadashi Yoshino, Giuseppe Zamboni, Yoh Zen, Suresh T. Chari - Arthritis & Rheumatism 2012 cited by 726

  18. Nationwide Epidemiological Survey of Autoimmune Pancreatitis in Japan in 2011

    Authors: , , , , , , , - Pancreas 2015 cited by 176

  19. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Gastroenterology 2022 cited by 119

  20. Nationwide epidemiological survey of immunoglobulin G4‐related disease with malignancy in Japan

    Authors: , , , , , , , , , , , , , , , , , - Journal of Gastroenterology and Hepatology 2022 cited by 27

  21. Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Pancreas 2011 cited by 290

  22. Japanese clinical practice guidelines for pancreaticobiliary maljunction

    Authors: , , , , , - Journal of Gastroenterology 2012 cited by 212

  23. Clinical practice guidelines for IgG4‐related sclerosing cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepato-Biliary-Pancreatic Sciences 2018 cited by 174

  24. Clinical diagnostic criteria of IgG4‐related sclerosing cholangitis 2012

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepato-Biliary-Pancreatic Sciences 2012 cited by 367